A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
03 10 2021
Historique:
pubmed: 3 7 2021
medline: 26 10 2021
entrez: 2 7 2021
Statut: ppublish

Résumé

In most countries of the Middle East and Northern African (MENA) region, a high hepatitis A virus (HAV) endemicity has been documented. Few others, such as Saudi Arabia and Turkey, are transitioning from high to intermediate endemicity. There is a paucity of recently published HAV disease burden that could be useful to inform or strengthen relevant national hepatitis A vaccination policy and other prevention strategies in the region. This review summarizes information on HAV epidemiology before and after the implementation of a childhood hepatitis A vaccination program in Saudi Arabia and Turkey. In both countries, a clear shift in the age of first HAV exposure has been documented, with more homogeneous trends across regions in Saudi Arabia compared to Turkey. Utilizing the experience of Saudi Arabia and Turkey with hepatitis A vaccination, countries in the region are encouraged to foster discussions on potential vaccination strategies suitable for their own setting.

Identifiants

pubmed: 34213403
doi: 10.1080/21645515.2021.1920871
pmc: PMC8437515
doi:

Substances chimiques

Hepatitis A Antibodies 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3710-3728

Références

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:6-8
pubmed: 25910370
Cold Spring Harb Perspect Med. 2018 Oct 1;8(10):
pubmed: 29500305
Saudi Med J. 2000 Oct;21(10):945-9
pubmed: 11369959
Int J Clin Exp Med. 2015 Oct 15;8(10):19394-9
pubmed: 26770581
Infect Control Hosp Epidemiol. 2006 Nov;27(11):1178-83
pubmed: 17080374
Clin Microbiol Infect. 2020 Mar;26(3):307-312
pubmed: 31284037
Environ Res. 2017 Jul;156:349-357
pubmed: 28391174
J Med Virol. 1986 Jun;19(2):151-3
pubmed: 3014060
Eur J Gastroenterol Hepatol. 2016 Mar;28(3):333-7
pubmed: 26703930
J Trop Pediatr. 1998 Feb;44(1):55-6
pubmed: 9538612
Curr Opin Infect Dis. 2015 Oct;28(5):488-96
pubmed: 26203853
Turk J Pediatr. 2011 Jan-Feb;53(1):114-6
pubmed: 21534354
J Egypt Public Health Assoc. 1999;74(3-4):227-39
pubmed: 17219868
Vaccine. 2014 Oct 21;32(46):6067-74
pubmed: 25236586
Turk J Pediatr. 2019;61(5):677-685
pubmed: 32104999
Med Sci Monit. 2018 Feb 15;24:936-943
pubmed: 29445079
Infect Dis Ther. 2019 Dec;8(4):483-497
pubmed: 31679118
Infez Med. 2017 Dec 1;25(4):339-343
pubmed: 29286012
Mil Med. 2003 Jul;168(7):565-8
pubmed: 12901469
Int J Infect Dis. 2010 Feb;14(2):e115-20
pubmed: 19540786
Turk J Gastroenterol. 2018 Mar;29(2):177-182
pubmed: 29749324
Int J Health Geogr. 2011 Oct 18;10:57
pubmed: 22008459
Int J Epidemiol. 2005 Jun;34(3):600-9
pubmed: 15831565
J Infect Public Health. 2020 Apr;13(4):480-484
pubmed: 32113699
Euroasian J Hepatogastroenterol. 2015 Jul-Dec;5(2):95-97
pubmed: 29201701
Pediatr Int. 2009 Feb;51(1):5-8
pubmed: 19371270
J Viral Hepat. 2008 Oct;15 Suppl 2:69-72
pubmed: 18837839
Med Sci Monit. 2008 Jan;14(1):CR52-56
pubmed: 18160946
Eur J Epidemiol. 2001;17(2):141-4
pubmed: 11599687
Ann Saudi Med. 2019 Jan-Feb;39(1):37-41
pubmed: 30712049
Saudi Med J. 2006 Oct;27(10):1515-22
pubmed: 17013474
Infection. 1993 Mar-Apr;21(2):132-3
pubmed: 8387965
Iran J Pediatr. 2013 Jun;23(3):276-80
pubmed: 23795249
J Paediatr Child Health. 2008 Apr;44(4):205-7
pubmed: 17999670
Pediatr Int. 2004 Dec;46(6):669-72
pubmed: 15660865
Wkly Epidemiol Rec. 2012 Jul 13;87(28/29):261–76
pubmed: 22905367
Travel Med Infect Dis. 2012 Jan;10(1):43-7
pubmed: 22264583
J Trop Pediatr. 2003 Dec;49(6):333-9
pubmed: 14725410
J Hepatol. 2017 Sep 5;:
pubmed: 28887164
Pediatrics. 2007 Jan;119(1):e22-9
pubmed: 17200247
J Infect Public Health. 2017 Sep - Oct;10(5):513-517
pubmed: 28162965
Hepatology. 2012 Aug;56(2):516-22
pubmed: 22371069
Ann Saudi Med. 1997 Jan;17(1):32-4
pubmed: 17377461
Int J Infect Dis. 2008 Nov;12(6):e141
pubmed: 18455942
World J Hepatol. 2012 Mar 27;4(3):68-73
pubmed: 22489258
J Viral Hepat. 2012 Jan;19(1):72-6
pubmed: 22187947
Saudi Med J. 1999 Sep;20(9):678-81
pubmed: 27645587
Turk J Pediatr. 2016;58(5):480-491
pubmed: 28621088
J Infect. 1986 Mar;12(2):153-5
pubmed: 3009629
Clin Infect Dis. 1995 Sep;21(3):621-7
pubmed: 8527554
Vaccine. 2010 Sep 24;28(41):6653-7
pubmed: 20723630
Turk J Pediatr. 2002 Jul-Sep;44(3):204-10
pubmed: 12405430
Vaccine. 2006 Jul 7;24(27-28):5599-603
pubmed: 16757065
J Infect Dis. 1983 Dec;148(6):1167
pubmed: 6317772
Saudi J Gastroenterol. 1995 May;1(2):93-6
pubmed: 19864857
Vaccine. 2011 Aug 26;29(37):6259-61
pubmed: 21763745
Epidemiol Infect. 2012 Dec;140(12):2172-81
pubmed: 22273572
Epidemiol Infect. 2004 Dec;132(6):1005-22
pubmed: 15635957
J Viral Hepat. 2007 Dec;14(12):830-4
pubmed: 18070285
J Viral Hepat. 2014;21(9):605-15
pubmed: 25040644
Health Policy. 2004 Mar;67(3):265-9
pubmed: 15036814
Turk J Med Sci. ;47(4):1055-1060
pubmed: 29152966
J Infect Dis. 2013 Feb 1;207(3):493-6
pubmed: 23204169
J Viral Hepat. 2008 Oct;15 Suppl 2:1-15
pubmed: 18837827

Auteurs

Selim Badur (S)

Medical & Clinical Emerging Markets, GSK, Istanbul, Turkey.

Serdar Öztürk (S)

Medical & Clinical Emerging Markets, GSK, Istanbul, Turkey.

Alev Ozakay (A)

Medical & Clinical Emerging Markets, GSK, Istanbul, Turkey.

Mansour Khalaf (M)

Medical Vaccines, GSK, Jeddah, Saudi Arabia.

Debasish Saha (D)

Medical & Clinical Emerging Markets, GSK, Wavre, Belgium.

Pierre Van Damme (P)

Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH